
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145744110.1021/acsomega.7b01966Addition/CorrectionCorrection to “S-Enantiomer of the Antitubercular
Compound S006-830 Complements Activity of Frontline TB Drugs and Targets
Biogenesis of Mycobacterium tuberculosis Cell Envelope” Singh Padam Kumar Shashi Kant Maurya Vineet Kumar Mehta Basant Kumar Ahmad Hafsa Dwivedi Anil Kumar Chaturvedi Vinita *Thakur Tejender S. *Sinha Sudhir *29 12 2017 31 12 2017 2 12 9287 9287 10 12 2017 Copyright © 2017 American Chemical
Society2017American Chemical
SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.ACS Omega2017, 2 (11), 8453−8465. DOI: 10.1021/acsomega.7b01281document-id-old-9ao7b01966document-id-new-14ao-2017-019662ccc-price
==== Body
Correction to page 8463. Under
the Headings “Molecular Docking” and “Accession
Codes”: The text (PDB ID: 3VIU) should be read as (PDB ID: 3V1U).

